American Association for Cancer Research

The Future of Cancer Research: Science and Patient Impact

AACR Roswell Park Cancer Institute

Docking study of a celecoxib derivative against PKA. Credit: Y. H. Tan, K. H. Lee, T. Lin, Y. C. Sun, H. M. Hsieh-Li, H. F. Juan,Y.C.Wang, Clin Cancer Res 2008 14: 1823-1830.



October 27 - 28, 2008
Roswell Park Cancer Institute
Buffalo, New York

DOWNLOAD BROCHURE*
*(Adobe Acrobat Reader required)

VIEW PROGRAM



The AACR Centennial Symposium: The Future of Cancer Research: Science and Patient Impact will focus on the latest and future advances in cancer research, technologies, and techniques. This forward-looking centennial symposium will also be honoring the long history that the AACR has had with the Roswell Park Cancer Institute. This symposium is a Continuing Medical Education (CME) activity, AMA PRA Category 1 Credits will be available.

CHAIRPERSONS:
Raymond N. DuBois, UT M. D. Anderson Cancer Center, Houston, TX
Donald L. Trump, Roswell Park Cancer Institute, Buffalo, NY

SCIENTIFIC PROGRAM COMMITTEE:
Alex A. Adjei, Roswell Park Cancer Institute, Buffalo, NY
Clara D. Bloomfield, Ohio State University Comprehensive Cancer Center, Columbus, OH
William S. Dalton, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
Roy S. Herbst, UT M.D. Anderson Cancer Center, Houston, TX
Candace S. Johnson, Roswell Park Cancer Institute, Buffalo, NY
Kelvin P. Lee, Roswell Park Cancer Institute, Buffalo, NY
Edwin A. Mirand, Roswell Park Cancer Institute, Buffalo, NY
William G. Nelson, V, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
Frank J. Rauscher, III, The Wistar Institute, Philadelphia, PA
Youcef M. Rustum, Roswell Park Cancer Institute, Buffalo, NY